vCJD screening and its implications for transfusion - Strategies for the future?

Blood Coagulation and Fibrinolysis

Volumn 14, Issue SUPPL. 1, 2003, Pages

  Turner, Marc L ^a,b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Blood transfusion; Risk; Screening; Variant Creutzfeldt Jakob disease

Indexed keywords

HEMOGLOBIN A; PRION PROTEIN;

BLOOD BRAIN BARRIER; BLOOD TRANSFUSION; BRAIN INJURY; BRAIN SPONGIOSIS; CASE CONTROL STUDY; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC APPROACH ROUTE; DISEASE TRANSMISSION; EPIDEMIOLOGICAL DATA; HEALTH SURVEY; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION RISK; LYMPHOID TISSUE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; ANIMALS; BIOLOGICAL MARKERS; BLOOD DONORS; BLOOD PROTEINS; BLOOD TRANSFUSION; CHILD; CREUTZFELDT-JAKOB SYNDROME; FEMALE; FOOD CONTAMINATION; FORECASTING; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RISK; SAFETY; SHEEP; SHEEP DISEASES;

EID: 0043127133     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200306001-00015     Document Type: Conference Paper

References (10)

1. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347:921-925.
2. Ironside JW, Head MW, Bell JE, McCardle L, Will RG. Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 2000; 37:1-9.
3. Mabbott NA, Farquhar CF, Brown KL, Bruce ME. Involvement of the immune system in TSE pathogenesis. Immunol Today 1998; 19:201-203.
4. Mabbott NA, Bruce ME, Botto M, Walport MJ, Pepys MB. Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med 2001; 7:485-487.
5. Mabbott NA, Mackay F, Minns F, Bruce ME. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med 2000; 6:719-720.
6. Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, Aguzzi A, Weissmann C. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 2000; 288:1257-1259.
7. Klein MA, Kaeser PS, Schwarz P, Weyd H, Xenarios I, Zinkernagel RM, et al. Complement facilitates early prion pathogenesis. Nat Med 2001; 7:488-492.
8. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000; 356:999-1000.
9. MacGregor I, Hope J, Barnard G, Kirby L, Drummond O, Pepper D, et al. Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components. Vox Sang 1999; 77:88-96.
10. Brown P, Cervenakova L, Diringer H. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 2001; 137:5-13.